121 related articles for article (PubMed ID: 3250152)
1. [Changes in behavior and central monoaminergic systems in the rat after repeated methamphetamine pretreatment: presynaptic regulatory mechanism].
Ichikawa J
Yakubutsu Seishin Kodo; 1988 Sep; 8(3):389-403. PubMed ID: 3250152
[TBL] [Abstract][Full Text] [Related]
2. NG-nitro-L-arginine methyl ester attenuates the maintenance and expression of methamphetamine-induced behavioral sensitization and enhancement of striatal dopamine release.
Inoue H; Arai I; Shibata S; Watanabe S
J Pharmacol Exp Ther; 1996 Jun; 277(3):1424-30. PubMed ID: 8667206
[TBL] [Abstract][Full Text] [Related]
3. [Experimental study of methamphetamine psychosis--role of glutamate and nitric oxide in methamphetamine-induced dopaminergic and serotonergic neurotoxicity in the rat brain].
Abekawa T
Hokkaido Igaku Zasshi; 1997 Jan; 72(1):113-26. PubMed ID: 9086367
[TBL] [Abstract][Full Text] [Related]
4. [Alteration of neuronal activities following repeated administration of stimulants].
Amano T; Matsubayashi H; Sasa M
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2002 Feb; 37(1):31-40. PubMed ID: 11915303
[TBL] [Abstract][Full Text] [Related]
5. Dopamine agonists at repeated "autoreceptor-selective" doses: effects upon the sensitivity of A10 dopamine autoreceptors.
Jeziorski M; White FJ
Synapse; 1989; 4(4):267-80. PubMed ID: 2603146
[TBL] [Abstract][Full Text] [Related]
6. Withdrawal from continuous or intermittent cocaine administration: changes in D2 receptor function.
King GR; Ellinwood EH; Silvia C; Joyner CM; Xue Z; Caron MG; Lee TH
J Pharmacol Exp Ther; 1994 May; 269(2):743-9. PubMed ID: 8182540
[TBL] [Abstract][Full Text] [Related]
7. Reversal of methamphetamine-induced behavioral sensitization by repeated administration of a dopamine D1 receptor agonist.
Shuto T; Kuroiwa M; Hamamura M; Yabuuchi K; Shimazoe T; Watanabe S; Nishi A; Yamamoto T
Neuropharmacology; 2006 Jun; 50(8):991-7. PubMed ID: 16563442
[TBL] [Abstract][Full Text] [Related]
8. Effect of antioxidant N-acetyl-L-cysteine on behavioral changes and neurotoxicity in rats after administration of methamphetamine.
Fukami G; Hashimoto K; Koike K; Okamura N; Shimizu E; Iyo M
Brain Res; 2004 Jul; 1016(1):90-5. PubMed ID: 15234256
[TBL] [Abstract][Full Text] [Related]
9. Neurochemical and behavioral evidence that Ro 41-9067 is a selective presynaptic dopamine receptor agonist.
Nisoli E; Tonello C; Imhof R; Scherschlicht R; da Prada M; Carruba MO
J Pharmacol Exp Ther; 1993 Jul; 266(1):97-105. PubMed ID: 8101225
[TBL] [Abstract][Full Text] [Related]
10. Protein expression profile in the striatum of rats with methamphetamine-induced behavioral sensitization.
Iwazaki T; McGregor IS; Matsumoto I
Proteomics; 2007 Apr; 7(7):1131-9. PubMed ID: 17351886
[TBL] [Abstract][Full Text] [Related]
11. The immunophilin ligand FK506 protects against methamphetamine-induced dopaminergic neurotoxicity in mouse striatum.
Koike K; Hashimoto K; Fukami G; Okamura N; Zhang L; Ohgake S; Koizumi H; Matsuzawa D; Kawamura N; Shimizu E; Iyo M
Neuropharmacology; 2005 Mar; 48(3):391-7. PubMed ID: 15721171
[TBL] [Abstract][Full Text] [Related]
12. [Changes of the dopamine uptake sites in the rat striatum induced by repeated methamphetamine administration: a neurochemical approach to a mechanism of relapse in amphetamine psychosis].
Nakayama M
Hokkaido Igaku Zasshi; 1993 Jul; 68(4):507-19. PubMed ID: 8340048
[TBL] [Abstract][Full Text] [Related]
13. [Effects of chronic alcohol administration on changes of extracellular dopamine and serotonin concentration induced by methamphetamine--comparison of two different alcohol preference rat lines].
Nishiguchi M; Kinoshita H; Taniguchi T; Utsumi T; Ouchi H; Minami T; Hishida S
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2002 Dec; 37(6):555-76. PubMed ID: 12607944
[TBL] [Abstract][Full Text] [Related]
14. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
Hu XT; White FJ
Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772
[TBL] [Abstract][Full Text] [Related]
15. Long-term changes in dopamine-stimulated gene expression after single-day methamphetamine exposure.
Belcher AM; O'Dell SJ; Marshall JF
Synapse; 2009 May; 63(5):403-12. PubMed ID: 19177510
[TBL] [Abstract][Full Text] [Related]
16. Noradrenergic modulation of methamphetamine-induced striatal dopamine depletion.
Fornai F; Alessandrì MG; Torracca MT; Bassi L; Scalori V; Corsini GU
Ann N Y Acad Sci; 1998 May; 844():166-77. PubMed ID: 9668674
[TBL] [Abstract][Full Text] [Related]
17. Repeated administration of a dopamine D1 receptor agonist reverses the increased proportions of striatal dopamine D1High and D2High receptors in methamphetamine-sensitized rats.
Shuto T; Seeman P; Kuroiwa M; Nishi A
Eur J Neurosci; 2008 May; 27(10):2551-7. PubMed ID: 18489579
[TBL] [Abstract][Full Text] [Related]
18. Maternal exposure to diphenhydramine during the fetal period in rats: effects on physical and neurobehavioral development and on neurochemical parameters.
Moraes AP; Schwarz A; Spinosa HS; Florio JC; Bernardi MM
Neurotoxicol Teratol; 2004; 26(5):681-92. PubMed ID: 15315817
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of phencyclidine-induced dopamine-dependent behaviors in rats after pretreatments with serotonin-depletors.
Yamaguchi K; Nabeshima T; Kameyama T
J Pharmacobiodyn; 1986 May; 9(5):479-89. PubMed ID: 2945001
[TBL] [Abstract][Full Text] [Related]
20. [Effects of antagonists of NMDA receptor on methamphetamine-induced decrease in the dopamine uptake sites in the rat striatum and on the behavioral sensitization].
Muraki A
Hokkaido Igaku Zasshi; 1993 May; 68(3):407-18. PubMed ID: 8319937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
